Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity

Jing Wang1, Pupu Ge1,2, Zehui Lei1,2

  • 1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China.

EMBO Reports
|May 3, 2021
PubMed

Insights

Mycobacterium tuberculosis protein kinase G (PknG) targets host immune proteins TRAF2 and TAK1 for degradation. This unusual enzyme disrupts NF-κB signaling, aiding bacterial survival and offering a potential tuberculosis treatment target.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Immunology

Background:

  • Mycobacterium tuberculosis (Mtb) infection involves pathogen protein kinase G (PknG) secreted into host macrophages.
  • PknG promotes Mtb intracellular survival, but its host interaction mechanisms are poorly understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which PknG interferes with host innate immune responses.
  • To investigate PknG's role in the ubiquitination and degradation of host proteins.

Main Methods:

  • Biochemical assays to determine PknG's enzymatic activities (E1, E3, isopeptidase).
  • In vitro ubiquitination assays using ubiquitin-conjugating enzyme UbcH7 and substrates TRAF2 and TAK1.
  • Analysis of NF-κB signaling pathway activation.

Main Results:

  • PknG functions as both a ubiquitin-activating enzyme (E1) and a ubiquitin ligase (E3).
  • PknG mediates the ubiquitination and degradation of TRAF2 and TAK1, key components of innate immunity.
  • PknG utilizes an unconventional mechanism involving UbcH7 and isopeptidase activity, inhibiting NF-κB signaling.

Conclusions:

  • PknG employs a unique ubiquitination strategy to dismantle host innate immune defenses.
  • Targeting PknG's enzymatic activity presents a novel therapeutic strategy for tuberculosis treatment.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
449
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.4K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
797
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K